Obesity. Obesity. Obesity. It's spreading everywhere and touches most every chronic health condition. Now researchers find obesity could affect how well long-term breast cancer treatments work.

Cancer tumors need an entire support structure of blood vessels to get the nutrients it needs to survive. A drug that goes after the support structure in metastatic breast cancer slows the progression of the disease, but doesn't prolong life.

We're obsessed with size in this country. And when it comes to breasts, size matters - a lot. Yet bigger is not always better in terms of breast cancer risks.

It was standard practice - women had their first mammograms at the age of 40. That changed in 2009 when the US Preventive Services Task Force ( USPSTF ) recommended against mammograms for this age group.

Exercise. Physical activity. Moving. Along with a clean and colorful diet, there's almost nothing better you can do for your body than move. The fact is we have to keep moving to keep moving, and here's another reason why.

A drug used to treat diabetes to might work on different kinds of cancer. One day, that may include breast cancer.

What if a simple blood test alerted you years in advance that you had elevated risks of breast cancer? Would you take it? You may have a choice in the near future.

The US Food and Drug Administration has approved a new drug to treat HER2-positive late-stage (metastatic) breast cancer. The drug has been shown to extend remission by about six months.

After the long process of designing, developing and testing new drugs, these meds are usually far more expensive than the older medications on the market. Are they better? Not always.

A class of drugs called CCR5 antagonists has revolutionized the care of HIV patients. These meds slow the disease from progressing to full-blown AIDS. A new preclinical study demonstrates these drugs may also be useful in cancer.